Veradermics, Inc — Director's Dealing 2026

Feb 6, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Veradermics, Inc (MANE)
CIK: 0001827635
Period of Report: 2026-02-03

Reporting Person: Friedman David Matthew (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-03	Stock Option (Right to Buy)	$17	A	43000	Acquired	2036-02-03	Common Stock (43000)	Direct

Footnotes

F1: Consists of options to purchase shares of the Issuer's common stock awarded to Mr. Friedman in connection with his role as a member of the Issuer's Board of Directors. Mr. Friedman, as an employee of Suvretta Capital Management, LLC ("Suvretta Capital"), the investment manager of Averill Master Fund, Ltd. and Averill Madison Master Fund, Ltd (the "Funds"), is holding such options for the benefit of the Funds, and as such Mr. Friedman disclaims beneficial ownership of such options. The Funds, and Suvretta Capital may be deemed to have an indirect pecuniary interest in such options because Suvretta Capital has rights to receive the benefit of director compensation provided in respect of Mr. Friedman's board service.

F2: This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.